Latest news from Datamonitor
pharmafile | August 15, 2008 | News story | Sales and Marketing |Â Â digiÂ
Clinical decision support tools, technologies that provide information to aid the diagnosis and treatment of patients, are set to make dramatic changes to the practice of medicine, according to a new report by Datamonitor. However, the report also predicts that aspects of medical culture will prove barriers to adoption.
Clinical intelligence solutions are predicted to be the next major trend in clinical decision support (CDS) tools, followed by patient-centric and diagnosis-related CDS. However, the report points out that medical culture will be the major obstacle to overcome in CDS adoption.
As more healthcare organizations realize the value of and need for electronic health records (EHRs), early adopters of EHRs are already moving to add more advanced functionalities, including CDS tools, to their EHRs. Without CDS, EHRs are not much more than a compilation of paper records in an electronic format. Thus, the rise in EHR adoption, as well as the increased focus on improving quality of care, is spurring interest in CDS.
CDS technologies range from online reference materials and guidelines, through alerts built into electronic prescribing (eRx) and computerized physician order entry (CPOE), to data mining and artificial intelligence. While most CDS tools today are targeted to providers – including hospitals, physicians, nurses, physician assistants, pharmacists and physical therapists – and payers, governments and patients will use CDS to a greater extent in the future.
CDS solutions improve patient care, potentially decrease healthcare costs over time and make it easier for providers to take part in pay-for-performance (P4P) initiatives. However, the fundamental cultural changes that need to take place in medicine, lack of technology adoption, and the steep investment that must be made to fully implement CDS, are high barriers to adoption.
According to Datamonitor, medical culture will provide the most resistance to CDS adoption. The idea that a computer could be more accurate than a physician is difficult for providers to accept, despite numerous studies which have shown that algorithms and computers do outperform most doctors on some tasks.
The 'art of medicine' is still highly regarded among providers, and critics of CDS maintain a computer cannot understand the nuances of medicine even when the technologies have been shown to improve efficiencies and outcomes. While a fundamental shift in culture is not impossible, it will take time as well as an increase in provider education and pressure from patients, payers and C-level hospital executives.
As the healthcare system becomes more patient-centric, CDS will as well. This focus on individual patients will be evident in a number of ways. For example, alerts and reminders will be personalized to each patient and genetic information will be included in patient records. Patients will even use CDS tools themselves to help aid in their own diagnosis and treatment.
Today's CDS solutions focus on aiding providers with their treatment plans for patients. While this is necessary, CDS should also be used by providers to help to diagnose patients. Misdiagnoses occur often in medicine; furthermore, the correct diagnosis is sometimes not reached until multiple incorrect diagnoses have been tested. With the technology and information available today, providers should not be complacent with the current misdiagnosis rate. If social networking tools like Facebook are able to predict who an individual might be friends with based on who he or she is already friends with, there is no reason that CDS should not be able to determine what diagnosis patients may have based on their health information. Despite the need to improve in this area, the use of CDS tools for diagnosis and computer-assisted diagnosis (CAD) technologies will be slow until a fundamental change in medical culture occurs.
The amount of clinical data available for research will grow exponentially with the greater adoption of EHRs, but the full value of the information collected will not be reached unless healthcare practitioners have the tools to analyze it.
Datamonitor believes business intelligence (BI) should be used not only for healthcare's financial data, but also its clinical data. CI, as some vendors are already calling it, is the application of BI tools to clinical data. Although the technology needs to be adapted slightly for clinical data, the main components remain the same. With more information and analysis, healthcare will be able to understand where it stands today, and therefore be able to determine where to invest resources to improve. After all, you cannot manage what you do not measure.
Currently, a minority, if any, of healthcare organizations are able to measure the mid- to long-term outcomes of the patients they treat, the number of incorrect diagnoses their providers make, how providers compare to each other, which procedures are most cost-effective, or whether prevention recommendations were given. Few understand the use of CDS technology itself.
Implementing most CDS tools is no easy feat. Even the low hanging fruit is difficult to pick, particularly if the technology is not user friendly. CPOE with CDS, for example, is already widely accepted, but rarely used appropriately. The main complaint that physicians have regarding CPOE with CDS is that too many inappropriate alerts pop up on the computer screen. Providers begin to ignore the alerts, even the correct ones, negating the reason why the alerts were set up in the first place. Alerts and reminders need to be accurate, relevant to the patient, unobtrusive to the provider's workflow and quick to use. Tracking how alerts are used and which are over-ridden may be the most valuable information for early adopters to share with their peers.
Similarly, CI solutions face their own set of implementation problems. CI may be great at analyzing data, but if the data the analysis was built upon are incorrect, then the validity of the research is compromised. Thus, the quality of the data being entered into EHRs must be verified. Finally, without interoperability, the capabilities of CDS will be limited as CI and alerts will not have the information they need to work well. The biggest barrier to interoperability is unfortunately not technology, but convincing all the stakeholders to participate, which is a much more difficult task to overcome.
CDS, it is important to note, will not replace the clinician. Rather, it is meant to aid providers and patients, allowing them to use all the information available to them effectively. The technology should allow clinicians to focus their energies on their patients and to provide better care rather than trying to retain information. With patients' lives at stake, technology vendors need to do more than pay lip service to the topic of interoperability.
Related research
Healthcare Technology Opportunities in the Electronic Health Record Market (Review Report)
Global Healthcare Technology Spending Forecast Through 2013 (Interactive Model)
Related Content
Video exclusive: PM Society Digital Awards 2010
Janssen was confirmed as one of the UK pharma industry’s most innovative pharma companies in …
Digital Pharma: No breakthrough, but UK’s digital issues out in the open
The UK’s Code of Practice regulator will produce guidance for pharma on digital marketing, but …
CMG launches digital division
Healthcare communications agency Complete Medical Group (CMG) has launched an online division to take advantage …
